The whole world is waiting for the Kovid-19 vaccine to survive the growing infection of the Corona virus. India is also involved in the race to make vaccines. India’s hopes on its Corona vaccine (Covaxin) remain. This vaccine has been prepared by Bharat Biotech and Indian Council of Medical Research (ICMR). Currently, the trial of this vaccine is going on. A senior government scientist with India Biotech’s Vaccine has said that if everything goes well, it is expected that the vaccine may come in February.
ICMR scientist Rajni Kant, who is a member of its Kovid-19 task force, said on Thursday that the vaccine has shown to be quite effective in the trials so far. He said that it is expected that something will be available by early February or March next year. However, nothing has been said on behalf of Bharat Biotech regarding the vaccine.
Let us know that after 10 days of new cases of Corona virus (Kovid-19) infection in the country, the number of infected again crossed this figure on Thursday. The main reason for this is the acceleration of infection in some states including Delhi, Kerala.
During the last 24 hours in India, 50209 new cases of corona were reported in different parts of the country. Earlier, their number was less than 50 thousand for 10 consecutive days. Together, the number of infection cases has crossed 83.64 lakh.
Rajni Kant, who heads ICMR’s Research Management, Policy, Planning and Coordination Cell, said it was up to the Ministry of Health to decide whether covacine doses could be given to people even before the Phase III trial was over. No. Kant said that the first and second phase trials of the vaccine have been quite visible.